BBA
AZN icon

BLB&B Advisors’s AstraZeneca AZN Stock Holding History

BLB&B Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,888
Closed -$336K – 253
2021
Q4 		$336K Sell
2,888
-3,491
-55% -$411K 0.02% 209
2021
Q3 		$766K Sell
6,379
-2,058
-24% -$240K 0.05% 150
2021
Q2 		$1.01M Sell
8,437
-6,250
-43% -$686K 0.07% 122
2021
Q1 		$1.46M Sell
14,687
-33,727
-70% -$3.39M 0.11% 102
2020
Q4 		$4.84M Buy
48,414
+3,429
+8% +$363K 0.39% 66
2020
Q3 		$4.93M Buy
44,985
+282
+0.6% +$31.4K 0.5% 60
2020
Q2 		$4.73M Sell
44,703
-3,206
-7% -$331K 0.51% 61
2020
Q1 		$4.28M Sell
47,909
-761
-2% -$71.6K 0.56% 59
2019
Q4 		$4.85M Sell
48,670
-865
-2% -$81.4K 0.5% 54
2019
Q3 		$4.42M Sell
49,535
-3,507
-7% -$304K 0.5% 56
2019
Q2 		$4.38M Sell
53,042
-750
-1% -$58.8K 0.5% 53
2019
Q1 		$4.35M Buy
53,792
+7,238
+16% +$571K 0.51% 50
2018
Q4 		$3.54M Buy
46,554
+1,931
+4% +$151K 0.49% 55
2018
Q3 		$3.53M Buy
44,623
+9,688
+28% +$733K 0.44% 63
2018
Q2 		$2.45M Buy
34,935
+5,079
+17% +$365K 0.33% 84
2018
Q1 		$2.09M Buy
29,856
+2,431
+9% +$168K 0.28% 93
2017
Q4 		$1.9M Buy
27,425
+15,694
+134% +$1.06M 0.27% 92
2017
Q3 		$795K Buy
+11,731
New +$741K 0.12% 149

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

BLB&B Advisors's AZN Position: Q1 2022 in Review

BLB&B Advisors sold out of AstraZeneca (AZN) in Q1 2022, closing a stake of 2,888 shares — an estimated $336K sold.

BLB&B Advisors first reported a position in AZN in Q3 2017 and held it in 18 quarters. The position peaked at $4.93M in Q3 2020. 982 funds tracked by Wall St. Rank hold AZN as of Q1 2022.

  • BLB&B Advisors reported no remaining AstraZeneca position as of Q1 2022 after selling out during the quarter.
  • BLB&B Advisors sold 2,888 AstraZeneca shares in Q1 2022, an estimated $336K.
  • BLB&B Advisors first reported a position in AstraZeneca in Q3 2017 and held it in 18 quarters.
  • BLB&B Advisors's AstraZeneca position peaked at $4.93M in Q3 2020.
  • 982 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2022.

Based on BLB&B Advisors's 13F filing for Q1 2022, filed 20 Apr 2022.